News | January 01, 2023
Briefs: Kilitch Drugs India, Family Care Hospitals and Krishna Institute of Medical Sciences
Krishna Institute of Medical Sciences to consider raising Rs. 300 crores
Krishna Institute of Medical Sciences to consider raising Rs. 300 crores
The company will submit an action plan on the observations and will engage with US FDA for next steps.
As per 10th edition of International Diabetes Federation (IDF) Atlas, 2021, India has 74.2 million people with diabetes between the age of 20-79 years
LHWRF will work with the State’s Department of Health and Family Welfare for strengthening the healthcare system and addressing the prevalence of CVD and COPD for better outcomes
The newly built complex of RRIUM, which will be under CCRUM, the apex government organization for research in Unani Medicine
This partnership aims to embed latest technological advancements in diagnosing and managing lung disorders and associated non-communicable diseases like asthma, pulmonary fibrosis and COPD.
India is at the forefront of research in cardiology worldwide but making indigenous products is what we are lacking & it needs to be improved
Lynparza is the first and only approved PARPi targeting BRCA-mutated HER2-negative high-risk early breast cancer
Apollo Hospital Group completed the acquisition of a hospital asset in Gurugram for a consideration of around Rs 450 crore.
AstraZeneca and Indian Society of Nephrology aim to help clinicians and healthcare practitioners to provide holistic kidney care to their patients.
Subscribe To Our Newsletter & Stay Updated
